Carvalho, R. F., Canto, L. M. d., Cury, S. S., Hansen, T. F., Jensen, L. H., & Rogatto, S. R. (2021). Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG.
Style de citation Chicago (17e éd.)Carvalho, Robson Francisco, Luisa Matos do Canto, Sarah Santiloni Cury, Torben Frøstrup Hansen, Lars Henrik Jensen, et Silvia Regina Rogatto. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG, 2021.
Style de citation MLA (8e éd.)Carvalho, Robson Francisco, et al. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG, 2021.